Fábio Rosa, co-founder of Asgard Therapeutics, was selected by Forbes among 30 brightest young entrepreneurs, innovators and game changers in Science and Healthcare segment. https://www.forbes.com/profile/fabio-rosa/#7376307670f8
Filipe Pereira, co-founder of Asgard Therapeutics, awarded with European Research Council (ERC) Consolidator Grant
The European Research Council (ERC) awarded Filipe Pereira, co-founder of Asgard Therapeutics, with an ERC Consolidator Grant to harness dendritic cell reprogramming towards the development of new patient-specific strategies for
Asgard Therapeutics won the Nordic Mentor Network for Entrepreneurship (NOME) Nordic entrepreneurship competition for promising life science companies and becomes part of the Novo Nordisk-funded NOME mentoring network.
Swedish start-up company Asgard Therapeutics has been awarded H2020 SMEi phase 1 in order to further develop a direct cell reprogramming technology for cancer immunotherapy. Asgard Therapeutics was founded in
Asgard Therapeutics won the Sten K Johnson Grant in the category of Medicine for projects with innovative ideas of medical importance that challenge traditional methods and concepts.
Asgard Therapeutics has been awarded Novo Seeds Exploratory Pre-seed Grant to develop dendritic cell reprogramming as a new approach for cancer immunotherapy.